Ventyx Biosciences to Participate in Two Upcoming Investor Conferences
Ventyx Biosciences, Inc. (VTYX)
Company Research
Source: GlobeNewswire
SAN DIEGO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”, “Company”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant unmet medical need, today announced that Company executives will participate in the following upcoming investor conferences: Event: 2024 Wells Fargo Healthcare ConferenceLocation: Boston, MADate: Wednesday, September 4, 2024Time: 11:00-11:35 AM ET Event: Morgan Stanley 22nd Annual Global Healthcare ConferenceLocation: New York, NYDate: Friday, September 6, 2024Time: 1:05-1:40 PM ET A webcast of the presentations will be available in the Investors and News section of the Ventyx website at www.ventyxbio.com. A webcast replay will also be available on this website shortly after conclusion of the event for thirty days. About Ventyx Biosciences Ventyx is a clinical-stage biopharmaceutical company focused o
Show less
Read more
Impact Snapshot
Event Time:
VTYX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VTYX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VTYX alerts
High impacting Ventyx Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
VTYX
News
- Ventyx Biosciences, Inc. (NASDAQ: VTYX) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.MarketBeat
- Ventyx Biosciences Announces $27 Million Strategic Investment from SanofiGlobeNewswire
- Ventyx Biosciences Announces Initiation of Dosing in a Phase 2a Trial of VTX3232 in Patients with Early Parkinson’s DiseaseGlobeNewswire
- Ventyx Biosciences Announces Departure of Chief Financial OfficerGlobeNewswire
- Ventyx Biosciences, Inc. (NASDAQ: VTYX) had its price target lowered by analysts at Wells Fargo & Company from $16.00 to $11.00. They now have an "overweight" rating on the stock.MarketBeat
VTYX
Earnings
- 8/8/24 - Beat
VTYX
Sec Filings
- 9/23/24 - Form 8-K
- 9/9/24 - Form 3
- 8/30/24 - Form 8-K
- VTYX's page on the SEC website